ConductScience.org, home

Paper27453079

Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study.

McCracken JT and 10 others. J Am Acad Child Adolesc Psychiatry, 2016. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study. Papers, record 27453079. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27453079

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study.
PubMed
Journal
J Am Acad Child Adolesc Psychiatry
PubMed
Year
2016
PubMed
Publication types
Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
2.22
iCite
Revised in PubMed
2022-03-10
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McCracken JTJames T
2McGough JJJames J
3Loo SKSandra K
4Levitt JJennifer
5Del'Homme MMelissa
6Cowen JJennifer
7Sturm AAlexandra
8Whelan FFiona
9Hellemann GGerhard
10Sugar CCatherine
11Bilder RMRobert M

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic alpha-2 Receptor AgonistsMajor topic
Attention Deficit Disorder with HyperactivityMajor topic
Central Nervous System StimulantsMajor topic
GuanfacineMajor topic
MethylphenidateMajor topic
Outcome Assessment, Health CareMajor topic
Adolescent
Child
Double-Blind Method
Drug Therapy, Combination
Female
Humans
Male

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P50 MH077248NIMH NIH HHSUnited StatesP50MH077248PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00429273Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity DisorderDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References57

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118182964Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis.J Am Acad Child Adolesc Psychiatry2008https://conductscience.org/library/papers/18182964PubMed
217277774Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory.Nat Neurosci2007https://conductscience.org/library/papers/17277774PubMed
311026169K-SADS-PL.J Am Acad Child Adolesc Psychiatry2000https://conductscience.org/library/papers/11026169PubMed
419153917Dopamine vs noradrenaline: inverted-U effects and ADHD theories.Aust N Z J Psychiatry2009https://conductscience.org/library/papers/19153917PubMed
521295057Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders.Pharmacol Biochem Behav2011https://conductscience.org/library/papers/21295057PubMed
618573145Neuropsychological outcome in adolescents/young adults with childhood ADHD: profiles of persisters, remitters and controls.J Child Psychol Psychiatry2008https://conductscience.org/library/papers/18573145PubMed
76135736Effects of stimulant drugs on academic performance in hyperactive and learning disabled children.J Learn Disabil1983https://conductscience.org/library/papers/6135736PubMed
817213010Remission versus response as the goal of therapy in ADHD: a new standard for the field?Clin Ther2006https://conductscience.org/library/papers/17213010PubMed
911211365Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.J Am Acad Child Adolesc Psychiatry2001https://conductscience.org/library/papers/11211365PubMed
1018166547A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.Pediatrics2008https://conductscience.org/library/papers/18166547PubMed
1116026226Dexmethylphenidate extended-release capsules for attention deficit hyperactivity disorder.Expert Rev Neurother2005https://conductscience.org/library/papers/16026226PubMed
1215213582Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment.J Am Acad Child Adolesc Psychiatry2004https://conductscience.org/library/papers/15213582PubMed
1319403491Positive association between attention-deficit/ hyperactivity disorder medication use and academic achievement during elementary school.Pediatrics2009https://conductscience.org/library/papers/19403491PubMed
1410591283A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.Arch Gen Psychiatry1999https://conductscience.org/library/papers/10591283PubMed
1515482034Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children.J Consult Clin Psychol2004https://conductscience.org/library/papers/15482034PubMed
168083146Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children.J Am Acad Child Adolesc Psychiatry1994https://conductscience.org/library/papers/8083146PubMed
179241475Toward a pathophysiology of attention-deficit/hyperactivity disorder.Clin Pediatr (Phila)1997https://conductscience.org/library/papers/9241475PubMed
182017529Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?Psychiatry Res1991https://conductscience.org/library/papers/2017529PubMed
1915213583Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment.J Am Acad Child Adolesc Psychiatry2004https://conductscience.org/library/papers/15213583PubMed
2015950006Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review.Biol Psychiatry2005https://conductscience.org/library/papers/15950006PubMed

See all 57 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
42135792Prescribing medications for attention-deficit/hyperactivity disorder in children: a retrospective analysis of a Japanese health insurance claims database.BMC Psychiatry2026https://conductscience.org/library/papers/42135792PubMed
41714759Structural integrity of the anterior thalamic radiation predicts alpha oscillations and inattention during visual encoding.Sci Rep2026https://conductscience.org/library/papers/41714759PubMed
40707201A retrospective single-center study on the characteristics of children with attention-deficit hyperactivity disorder requiring early drug therapy from 2013 to 2022 and changes in treatment over time.Fukushima J Med Sci2026https://conductscience.org/library/papers/40707201PubMed
40150587Cardiological Findings in Children and Adolescents Before and After Guanfacine Treatment for Attention Deficit and Hyperactivity Disorder.Children (Basel)2025https://conductscience.org/library/papers/40150587PubMed
39562458Translating Decades of Neuroscience Research into Diagnostic and Treatment Biomarkers for ADHD.Adv Neurobiol2024https://conductscience.org/library/papers/39562458PubMed
38027301
Case Report: Guanfacine and methylphenidate improved chronic lower back pain in autosomal dominant polycystic kidney disease with comorbid attention deficit hyperactivity disorder and autism spectrum disorder.
Front Pediatr2023https://conductscience.org/library/papers/38027301PubMed
37495853Adrenoceptors: A Focus on Psychiatric Disorders and Their Treatments.Handb Exp Pharmacol2024https://conductscience.org/library/papers/37495853PubMed
37218982The Role of Alpha-2 Agonists for Attention Deficit Hyperactivity Disorder in Children: A Review.Neurol Int2023https://conductscience.org/library/papers/37218982PubMed
36971690Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).Cochrane Database Syst Rev2023https://conductscience.org/library/papers/36971690PubMed
36590311Inter-hemispheric Asymmetry Patterns in the ADHD Brain: A Neuroimaging Replication Study.Proc SPIE Int Soc Opt Eng2019https://conductscience.org/library/papers/36590311PubMed
36476096Common practical questions - and answers - at the British Association for Psychopharmacology child and adolescent psychopharmacology course.J Psychopharmacol2023https://conductscience.org/library/papers/36476096PubMed
35963559Electrophysiological and Clinical Predictors of Methylphenidate, Guanfacine, and Combined Treatment Outcomes in Children With Attention-Deficit/Hyperactivity Disorder.J Am Acad Child Adolesc Psychiatry2023https://conductscience.org/library/papers/35963559PubMed
35963558Methylphenidate, Guanfacine, and Combined Treatment Effects on Electroencephalography Correlates of Spatial Working Memory in Attention-Deficit/Hyperactivity Disorder.J Am Acad Child Adolesc Psychiatry2023https://conductscience.org/library/papers/35963558PubMed
35507283New Drugs to Treat ADHD: Opportunities and Challenges in Research and Development.Curr Top Behav Neurosci2022https://conductscience.org/library/papers/35507283PubMed
34411767Inhibitory control in youth with Tourette's Disorder, attention-deficit/hyperactivity disorder and their combination and predictors of objective tic suppressibility.Psychiatry Res2021https://conductscience.org/library/papers/34411767PubMed
34403134A Practical, Evidence-informed Approach to Managing Stimulant-Refractory Attention Deficit Hyperactivity Disorder (ADHD).CNS Drugs2021https://conductscience.org/library/papers/34403134PubMed
33075480Guanfacine's mechanism of action in treating prefrontal cortical disorders: Successful translation across species.Neurobiol Learn Mem2020https://conductscience.org/library/papers/33075480PubMed
30942617Weight and Height in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Longitudinal Database Study Assessing the Impact of Guanfacine, Stimulants, and No Pharmacotherapy.J Child Adolesc Psychopharmacol2019https://conductscience.org/library/papers/30942617PubMed
30883769Alpha modulation during working memory encoding predicts neurocognitive impairment in ADHD.J Child Psychol Psychiatry2019https://conductscience.org/library/papers/30883769PubMed
30116086Guanfacine hydrochloride for attention deficit hyperactivity disorder.Aust Prescr2018https://conductscience.org/library/papers/30116086PubMed

See all 27 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IGKV2D-2928882PubTator's text mininghttps://conductscience.org/library/genes/28882NCBI Gene
LMOD125802PubTator's text mininghttps://conductscience.org/library/genes/25802NCBI Gene

Download CSV of genes

Drugs2

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
METHYLPHENIDATECHEMBL796Derived from the trial1https://conductscience.org/library/drugs/CHEMBL796ChEMBL
GUANFACINECHEMBL862Derived from the trial1https://conductscience.org/library/drugs/CHEMBL862ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/27453079

GET https://conductscience.org/api/papers/v1/27453079/references?page=2